Todd D. Schell
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
Papers in
- Immunology 56
- Immunotherapy and Immune Responses 41
- T-cell and B-cell Immunology 22
- Oncology 35
- Cancer Immunotherapy and Biomarkers 24
- Polyomavirus and related diseases 4
- Cancer Cells and Metastasis 3
- CAR-T cell therapy research 3
- Co-authors
- Satvir S. Tevethia (21 shared papers)David F. Claxton (8 shared papers)Hong Zheng (9 shared papers)Witold B. Rybka (7 shared papers)William Christopher Ehmann (7 shared papers)Lawrence M. Mylin (9 shared papers)Joseph J. Drabick (10 shared papers)Gavin P. Robertson (9 shared papers)
- Journals
- The Journal of Immunology (17 papers)Cancer Immunology Immunotherapy (5 papers)OncoImmunology (4 papers)Journal of Virology (4 papers)Cancer Biology & Therapy (4 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Todd D. Schell
91 papers receiving 3.5k citations
Todd D. Schell's Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 1.4k
- Immunology 1.2k
- Hematology 228
- Hepatology 99
- Cancer Research 141
Countries citing papers authored by Todd D. Schell
This map shows the geographic impact of Todd D. Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd D. Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd D. Schell more than expected).
Fields of papers citing papers by Todd D. Schell
This network shows the impact of papers produced by Todd D. Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd D. Schell. The network helps show where Todd D. Schell may publish in the future.
Co-authors
The 25 scholars most cited alongside Todd D. Schell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis Hit paper breakdown → | 2016 | 567 |
| 2 | 2016 | 254 | |
| 3 | 2017 | 158 | |
| 4 | 2016 | 136 | |
| 5 | 2018 | 134 | |
| 6 | 2015 | 130 | |
| 7 | 2022 | 106 | |
| 8 | 2004 | 101 | |
| 9 | 2014 | 97 | |
| 10 | 2000 | 84 | |
| 11 | 2017 | 83 | |
| 12 | 2012 | 79 | |
| 13 | 2003 | 76 | |
| 14 | 2003 | 72 | |
| 15 | 1998 | 68 | |
| 16 | 2017 | 56 | |
| 17 | 2017 | 55 | |
| 18 | 2018 | 55 | |
| 19 | 2003 | 54 | |
| 20 | 2019 | 54 |
About Todd D. Schell
Todd D. Schell is a scholar working on Immunology, Oncology, Hematology, Molecular Biology and Biochemistry, having authored 96 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (41 papers), Cancer Immunotherapy and Biomarkers (24 papers), T-cell and B-cell Immunology (22 papers), vaccines and immunoinformatics approaches (8 papers), Polyomavirus and related diseases (4 papers), Cancer Cells and Metastasis (3 papers), Acute Myeloid Leukemia Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (1.2k citations), Hematology (228 citations), Hepatology (99 citations) and Cancer Research (141 citations). Todd D. Schell has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Satvir S. Tevethia, David F. Claxton, Hong Zheng, Witold B. Rybka, William Christopher Ehmann, Lawrence M. Mylin, Joseph J. Drabick, Gavin P. Robertson, Hui Zeng and Peter Lauer. Their work appears in journals such as The Journal of Immunology, Cancer Immunology Immunotherapy, OncoImmunology, Journal of Virology and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.